Search Results - "Agrawal, N G B"

A Question-Based Approach to Adopting Pharmacogenetics to Understand Risk for Clinical Variability in Pharmacokinetics in Early Drug Development by Evers, R, Blanchard, R L, Warner, A W, Cutler, D, Agrawal, N G B, Shaw, P M

“…Understanding genetic variations that influence pharmacokinetics (PK) in humans is important for optimal clinical use of drugs. Guidances for making decisions…”
Get full text

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers by de Haas, S L, de Visser, S J, van der Post, J P, de Smet, M, Schoemaker, R C, Rijnbeek, B, Cohen, A F, Vega, J M, Agrawal, N G B, Goel, T V, Simpson, R C, Pearson, L K, Li, S, Hesney, M, Murphy, M G, van Gerven, J M A

“…TPA023, a GABA(A) alpha2,3 alphasubtype-selective partial agonist, is expected to have comparable anxiolytic efficacy as benzodiazepines with reduced sedating…”
Get full text

Pharmacodynamic and pharmacokinetic effects of TPA023, a GABAA α2,3 subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers by de Haas, S.L., de Visser, S.J., van der Post, J.P., de Smet, M., Schoemaker, R.C., Rijnbeek, B., Cohen, A.F., Vega, J.M., Agrawal, N.G.B., Goel, T.V., Simpson, R.C., Pearson, L.K., Li, S., Hesney, M., Murphy, M.G., van Gerven, J.M.A.

“…TPA023, a GABAA α2,3 αsubtype-selective partial agonist, is expected to have comparable anxiolytic efficacy as benzodiazepines with reduced sedating effects…”
Get full text

Effect of Pore Geometry on Ring Closure Selectivities in Platinum L-Zeolite Dehydrocyclization Catalysts by Miller, J.T., Agrawal, N.G.B., Lane, G.S., Modica, F.S.

“…Experimental evaluations of nonacidic supported platinum catalysts for the conversion ofn-hexane to benzene demonstrate that the support geometry plays a major…”
Get full text

THE PHARMACOKINETICS OF CO-ADMINISTRATION OF ETORICOXIB AND ORAL CONTRACEPTIVES IN HEALTHY SUBJECTS: 125 by Schwartz, J I, Agrawal, N GB, Larson, P J, Crumley, T M, Gottesdiener, K

Get full text

EFFECT OF INCREASING DOSES OF ETORICOXIB ON ORAL METHOTREXATE PHARMACOKINETICS IN PATIENTS WITH RHEUMATOID ARTHRITIS: 124 by Schwartz, J I, Agrawal, N GB, Wong, P H, Miller, J L, Mehta, A, Bachmann, K, Marbury, T, Hoelscher, D, Gottesdiener, K

Get full text